Skip to main content
Top
Published in: International Urogynecology Journal 8/2011

01-08-2011 | Original Article

The effect of solifenacin on urethral sphincter morphology

Authors: Jonathan Duckett, Maya Basu

Published in: International Urogynecology Journal | Issue 8/2011

Login to get access

Abstract

Introduction and hypothesis

The aim of the study was to determine whether a 6-week course of 5 mg of solifenacin succinate used to treat mixed incontinence, produces measurable changes in the appearance of the urethral sphincter.

Methods

Twenty-six women undergoing treatment for mixed incontinence were recruited from a urogynaecology unit after failing to improve with conservative treatments and bladder drill. All underwent dual channel subtracted cystometry, which showed mixed urodynamic stress incontinence and detrusor overactivity. All patients underwent a 3D transperineal ultrasound before solifenacin therapy was started and after 6 weeks of treatment. The urethral length, width and volume of the smooth muscle and total sphincter volume were compared before and after the treatment.

Results

Clinically, 13 reported no improvement in either stress or urge incontinence. Eight women reported improvement in their urgency symptoms but no benefit in their stress leakage. Four women reported resolution of both stress and urge incontinence. One woman reported worsening of her bladder symptoms. There was no significant change in the urethral length (p = 0.27), width (p = 0.50), volume of smooth muscle (p = 0.87) or total sphincter volume (p = 0.60) before and after treatment with solifenacin.

Conclusions

A 6-week course of solifenacin resulted in no measurable changes in the appearance of the urethral sphincter.
Literature
2.
go back to reference Haylen BT, de Ridder D, Freeman RM et al (2010) An International Urogynecological association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J Pelvic Floor Dysfunct 21:5–26CrossRef Haylen BT, de Ridder D, Freeman RM et al (2010) An International Urogynecological association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J Pelvic Floor Dysfunct 21:5–26CrossRef
3.
go back to reference Ward K, Hilton P (2002) Prospective multicentre randomised trial of tension-free vaginal tape and colposuspension as primary treatment for stress incontinence. BMJ 325:67–70PubMedCrossRef Ward K, Hilton P (2002) Prospective multicentre randomised trial of tension-free vaginal tape and colposuspension as primary treatment for stress incontinence. BMJ 325:67–70PubMedCrossRef
4.
go back to reference Chapple CR, Rechberger T, Al-Shukri S, Meffan P, Everaert K, Huang M, Ridder A (2004) Randomized, double-blind placebo and tolterodine-controlled trial of the once daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder. BJU Int 93:303–310PubMedCrossRef Chapple CR, Rechberger T, Al-Shukri S, Meffan P, Everaert K, Huang M, Ridder A (2004) Randomized, double-blind placebo and tolterodine-controlled trial of the once daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder. BJU Int 93:303–310PubMedCrossRef
5.
go back to reference Cardozo L, Castro-Diaz D, Gittelman M, Ridder A, Huang M (2006) Reductions in overactive bladder related incontinence from pooled analysis of phase 111 trials evaluating treatment with solifenacin. Int Urogynecol J Pelvic Floor Dysfunct 17:512–519PubMedCrossRef Cardozo L, Castro-Diaz D, Gittelman M, Ridder A, Huang M (2006) Reductions in overactive bladder related incontinence from pooled analysis of phase 111 trials evaluating treatment with solifenacin. Int Urogynecol J Pelvic Floor Dysfunct 17:512–519PubMedCrossRef
6.
go back to reference Kelleher C, Cardozo L, Kobashi K, Lucente V (2006) Solifenacin: as effective in mixed incontinence as in urge incontinence. Int Urogynecol J Pelvic Floor Dysfunct 17:382–388PubMedCrossRef Kelleher C, Cardozo L, Kobashi K, Lucente V (2006) Solifenacin: as effective in mixed incontinence as in urge incontinence. Int Urogynecol J Pelvic Floor Dysfunct 17:382–388PubMedCrossRef
7.
go back to reference Diokno AC, Appell RA, Sand PK, The Opera Study Group et al (2003) Prospective, randomized, double-blind study of the efficacy and tolerability of the extended release formulations of oxybutynin and tolterodine for overactive bladder; results of eth OPERA trial. Mayo Clin Proc 78:687–695PubMedCrossRef Diokno AC, Appell RA, Sand PK, The Opera Study Group et al (2003) Prospective, randomized, double-blind study of the efficacy and tolerability of the extended release formulations of oxybutynin and tolterodine for overactive bladder; results of eth OPERA trial. Mayo Clin Proc 78:687–695PubMedCrossRef
8.
go back to reference Panayi DC, Trekkis P, Fernando R, Khullar V (2010) Is the beneficial effect of antimuscarinics related to motor or sensory changes in the bladder? Int Urogynecol J Pelvic Floor Dysfunct 21:841–845CrossRef Panayi DC, Trekkis P, Fernando R, Khullar V (2010) Is the beneficial effect of antimuscarinics related to motor or sensory changes in the bladder? Int Urogynecol J Pelvic Floor Dysfunct 21:841–845CrossRef
9.
go back to reference Khullar V (2001) Ultrasonography. In: Cardozo L, Staskin D (eds) Textbook of female urology and urogynecology. Martin Dunitz, London, pp 299–312 Khullar V (2001) Ultrasonography. In: Cardozo L, Staskin D (eds) Textbook of female urology and urogynecology. Martin Dunitz, London, pp 299–312
10.
go back to reference Khullar V, Athanasiou S, Cardozo LD, Boos K, Salvatore S, Young M (1996) Histological correlates of the urethral sphincter and surrounding structures with ultrasound findings. Int Urogynecol J Pelvic Floor Dysfunct 7:164, abstract O47 Khullar V, Athanasiou S, Cardozo LD, Boos K, Salvatore S, Young M (1996) Histological correlates of the urethral sphincter and surrounding structures with ultrasound findings. Int Urogynecol J Pelvic Floor Dysfunct 7:164, abstract O47
11.
go back to reference Schaer GN, Schmid T, Peschers U, Delancy JOL (1998) Intraurethral ultrasound correlated with urethral histology. Obstet Gynecol 91:60–64PubMedCrossRef Schaer GN, Schmid T, Peschers U, Delancy JOL (1998) Intraurethral ultrasound correlated with urethral histology. Obstet Gynecol 91:60–64PubMedCrossRef
12.
go back to reference Machin D, Campbell M, Fayers P, Pinol A (1997) Sample size tables for clinical studies. Blackwell, Oxford Machin D, Campbell M, Fayers P, Pinol A (1997) Sample size tables for clinical studies. Blackwell, Oxford
13.
go back to reference Khullar V, Salvatore S, Cardozo l, Bourne TH, Abbott D, Kelleher C (1994) A novel technique for measuring bladder wall thickness in women using transvaginal ultrasound. Ultrasound Obstet Gynecol 4:220–223PubMedCrossRef Khullar V, Salvatore S, Cardozo l, Bourne TH, Abbott D, Kelleher C (1994) A novel technique for measuring bladder wall thickness in women using transvaginal ultrasound. Ultrasound Obstet Gynecol 4:220–223PubMedCrossRef
14.
go back to reference Duckett J, Patil A, Aggarwal I (2008) The effect of duloxetine on urethral sphincter morphology. Ultrasound Obstet Gynecol 31:206–209PubMedCrossRef Duckett J, Patil A, Aggarwal I (2008) The effect of duloxetine on urethral sphincter morphology. Ultrasound Obstet Gynecol 31:206–209PubMedCrossRef
15.
go back to reference Athanasiou S, Khullar V, Boos K, Salvatore S, Cardozo L (1999) Imaging the urethral sphincter with three-dimensional ultrasound. Obstet Gynecol 94:295–301PubMedCrossRef Athanasiou S, Khullar V, Boos K, Salvatore S, Cardozo L (1999) Imaging the urethral sphincter with three-dimensional ultrasound. Obstet Gynecol 94:295–301PubMedCrossRef
16.
go back to reference Athanasiou S, Chaliha C, Digesu GA, Sotiropoulou M, Georgoulias N, Khullar V, Antsakilis A (2007) The effects of duloxetine on urethral function and sphincter morphology. Int Urogynecol J Pelvic Floor Dysfunct 18:763–767PubMedCrossRef Athanasiou S, Chaliha C, Digesu GA, Sotiropoulou M, Georgoulias N, Khullar V, Antsakilis A (2007) The effects of duloxetine on urethral function and sphincter morphology. Int Urogynecol J Pelvic Floor Dysfunct 18:763–767PubMedCrossRef
17.
go back to reference deSouza NM, Daniels OJ, Williams AD, Gilderdale DJ, Abel PD (2002) Female urinary genuine stress incontinence; anatomical considerations at MR imaging of the paravaginal fascia and urethra initial observations. Radiology 225:433–439PubMedCrossRef deSouza NM, Daniels OJ, Williams AD, Gilderdale DJ, Abel PD (2002) Female urinary genuine stress incontinence; anatomical considerations at MR imaging of the paravaginal fascia and urethra initial observations. Radiology 225:433–439PubMedCrossRef
18.
go back to reference Toozs-Hobson P, Khullar V, Cardozo L (2001) Three-dimensional ultrasound; a novel technique for investigating the urethral sphincter in the third trimester of pregnancy. Ultrasound Obstet Gynecol 17:421–424PubMedCrossRef Toozs-Hobson P, Khullar V, Cardozo L (2001) Three-dimensional ultrasound; a novel technique for investigating the urethral sphincter in the third trimester of pregnancy. Ultrasound Obstet Gynecol 17:421–424PubMedCrossRef
19.
go back to reference Hirst GR, Beeton RJ, Lucas MG (2010) Static single channel and multichannel water perfusion profilometry in a bench model of the urethra. Neurourol Urodyn 29:1312–1319PubMedCrossRef Hirst GR, Beeton RJ, Lucas MG (2010) Static single channel and multichannel water perfusion profilometry in a bench model of the urethra. Neurourol Urodyn 29:1312–1319PubMedCrossRef
Metadata
Title
The effect of solifenacin on urethral sphincter morphology
Authors
Jonathan Duckett
Maya Basu
Publication date
01-08-2011
Publisher
Springer-Verlag
Published in
International Urogynecology Journal / Issue 8/2011
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-011-1410-7

Other articles of this Issue 8/2011

International Urogynecology Journal 8/2011 Go to the issue